Abbott Laboratories (ABT) Dividends Paid - Common (2009 - 2026)

Abbott Laboratories has disclosed Dividends Paid - Common across 18 years of filings, most recently posting $1.1 billion for Q1 2026.

• Dividends Paid - Common for Q1 2026 came in at $1.1 billion, up 7.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 billion (up 7.25% YoY), and the FY2025 annual result was $4.1 billion, up 7.3% from the prior year.
• Dividends Paid - Common came in at $1.1 billion for Q1 2026 at Abbott Laboratories, up from $1.0 billion in the prior quarter.
• In the past five years, Dividends Paid - Common ranged from a high of $1.1 billion in Q1 2026 to a low of $823.0 million in Q4 2022.
• The 5-year median for Dividends Paid - Common is $957.0 million (2024), against an average of $936.2 million.
• Across the five-year window, Dividends Paid - Common climbed 3.11% in 2022 and increased 8.11% in 2024, its largest moves.
• Abbott Laboratories' Dividends Paid - Common stood at $823.0 million in 2022, then grew by 7.9% to $888.0 million in 2023, then rose by 7.88% to $958.0 million in 2024, then increased by 7.52% to $1.0 billion in 2025, then grew by 6.6% to $1.1 billion in 2026.
• The last three Dividends Paid - Common figures came in at $1.1 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.0 billion (Q3 2025), per Business Quant data.